Pharmaceutical News

RSS

First treatment approved by FDA for chronic rhinosinusitis with nasal polyps

The U.S. Food and Drug Administration today approved Dupixent (dupilumab) to treat adults with nasal polyps (growths on the inner lining of the sinuses) accompanied by chronic rhinosinusitis (prolonged inflammation of the sinuses and nasal cavity).

26 Jun 2019

Interaction between antidepressants and opioid pain medication contributes to lesser pain relief

Common antidepressants interact with the opioid pain medication tramadol to make it less effective for pain relief, according to a study from University Hospitals.

26 Jun 2019

New class of radiopharmaceuticals offer fresh perspective on cancer imaging, theranostics

Research presented at the 2019 Annual Meeting of the Society of Nuclear Medicine and Molecular Imaging describes a new class of radiopharmaceuticals, named radiohybrids, that offer a fresh perspective on cancer imaging and radioligand therapy.

26 Jun 2019

Cholesterol-lowering drugs could increase risk of developing diabetes

A study of thousands of patients' health records found that those who were prescribed cholesterol-lowering statins had at least double the risk of developing type 2 diabetes.

25 Jun 2019

Natural antibiotic made by Tübingen researchers interacts with human defense mechanisms

The natural antibiotic Lugdunin, discovered three years ago by Tübingen researchers, attacks pathogenic bacteria in several different ways simultaneously.

24 Jun 2019

Diabetes drug can halve the risk of late miscarriage, preterm births for women with PCOS

Metformin can halve the risk of late miscarriage and preterm births for women with polycystic ovary syndrome.

24 Jun 2019

Oral steroid use in patients with inflammatory diseases increases risk of infection

Oral steroid use in patients with the inflammatory diseases polymyalgia rheumatica and/or giant cell arteritis significantly increased the risk of infection, and the risk increased with higher doses, found a study in CMAJ.

24 Jun 2019

Unregulated pharmacy benefit manager practices may contribute to escalating expenses

Efforts to control health care costs in the United States often focus on the listed prescription drug prices, but a perspective published by the Journal of the American Medical Association suggests that unregulated pharmacy benefit manager practices also may contribute to escalating expenses.

24 Jun 2019

FDA approves new drug to treat hypoactive sexual desire disorder in premenopausal women

The U.S. Food and Drug Administration today approved Vyleesi (bremelanotide) to treat acquired, generalized hypoactive sexual desire disorder in premenopausal women.

23 Jun 2019

FDA expands approval of cystic fibrosis treatment to include pediatric patients as young as 6 years old

The U.S. Food and Drug Administration today expanded the indication for Symdeko (a combination of tezacaftor/ivacaftor) tablets for treatment of pediatric patients ages 6 years and older with cystic fibrosis who have certain genetic mutations.

22 Jun 2019

Most preferred drug for HIV may not be as safe as suggested

A study lead by researchers at the Institute of HIV Research, Medical Faculty of UDE and University Hospital Essen, stumbled over a potential toxicity of integrase inhibitors.

21 Jun 2019

Surgeons’ opioid-prescribing habits hard to kick

As opioid addiction and deadly overdoses escalated into an epidemic across the U.S., thousands of surgeons continued to hand out far more pills than needed for postoperative pain relief, according to a KHN-Johns Hopkins analysis of Medicare data.

21 Jun 2019

New study shows clear link between cannabis use and brain alterations

A once understudied topic now shows a clear link between cannabis use and brain alterations, whereby chronic use may lead to poor conflict resolution skills

21 Jun 2019

Survey: Slow adoption of new technology is impacting pharmacy services

A new survey released today (20th June 2019), has found that 87% of pharmacists believe the profession has been slow in its adoption of new technology when compared to other sectors.

20 Jun 2019

Revolutionary cancer drugs that target any tumor to be fast-tracked into hospitals by NHS

Patients in England could be some of the first in the world to be treated with revolutionary cancer drugs that can target any type of tumor.

19 Jun 2019

Antidepressant treatment leads to impaired empathy regarding perception of pain

Antidepressant treatment, not only depression per se, can lead to reductions in behavioral and neural responses to pain empathy

18 Jun 2019

FDA approves first non-insulin drug for treatment of pediatric patients with type 2 diabetes

The U.S. Food and Drug Administration today approved Victoza (liraglutide) injection for treatment of pediatric patients 10 years or older with type 2 diabetes.

18 Jun 2019

Blood pressure drug appears to be helpful for people with Alzheimer's disease

Seeking new treatments to slow the progression of Alzheimer's disease, researchers found the blood pressure drug nilvadipine increased blood flow to the brain's memory and learning center among people with Alzheimer's disease without affecting other parts of the brain, according to new research in the American Heart Association's journal Hypertension.

17 Jun 2019

Scientists improve working memory by extending brain signals

Researchers have discovered that short term memory can be improved by artificially extending neuronal signals called sharp wave ripples.

14 Jun 2019

Heart failure drug could be effective in treating leukemia

Canadian researchers followed their intuition that a drug initially intended for heart failure could be effective in treating cancer. Those efforts have borne fruit, as demonstrated by their work published in the Journal of Experimental and Clinical Cancer Research.

13 Jun 2019

Pharmaceutical News

First treatment approved by FDA for chronic rhinosinusitis with nasal polyps

Interaction between antidepressants and opioid pain medication contributes to lesser pain relief

New class of radiopharmaceuticals offer fresh perspective on cancer imaging, theranostics

Cholesterol-lowering drugs could increase risk of developing diabetes

Natural antibiotic made by Tübingen researchers interacts with human defense mechanisms

Diabetes drug can halve the risk of late miscarriage, preterm births for women with PCOS

Oral steroid use in patients with inflammatory diseases increases risk of infection

Unregulated pharmacy benefit manager practices may contribute to escalating expenses

FDA approves new drug to treat hypoactive sexual desire disorder in premenopausal women

FDA expands approval of cystic fibrosis treatment to include pediatric patients as young as 6 years old

Most preferred drug for HIV may not be as safe as suggested

Surgeons’ opioid-prescribing habits hard to kick

New study shows clear link between cannabis use and brain alterations

Survey: Slow adoption of new technology is impacting pharmacy services

Revolutionary cancer drugs that target any tumor to be fast-tracked into hospitals by NHS

Antidepressant treatment leads to impaired empathy regarding perception of pain

FDA approves first non-insulin drug for treatment of pediatric patients with type 2 diabetes

Blood pressure drug appears to be helpful for people with Alzheimer's disease

Scientists improve working memory by extending brain signals

Heart failure drug could be effective in treating leukemia

Edoardo Fabini

Reducing polypharmacy through innovative drug formulation technologies

How innovation in dried blood spot testing is transforming neurological disease monitoring

Latest News